ERYTECH reports financial highlights for Q4 2014 and updates on upcoming milestones admERY February 10, 2015 Newsroom ERYTECH reports revenues and cash balance for the fourth quarter of 2014 and provides an update on upcoming milestones. You Might Also Like ERYTECH Pharma signs licensing and distribution agreement with Orphan Europe for GRASPA® in Europe November 23, 2012 ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference October 9, 2018 ERYTECH Reports Third Quarter 2017 Financial Results and Provides Business Update November 6, 2017
ERYTECH Pharma signs licensing and distribution agreement with Orphan Europe for GRASPA® in Europe November 23, 2012
